Search Results

Corplex P/Theracor P/Allacor P is indicated for use in the management of the following wounds: - · Partial and full-thickness wounds - Pressure ulcers - Venous ulcers - · Diabetic ulcers - · Chronic vascular ulcers - · Tunneled/undermined wounds - · Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) - · Trauma wounds (abrasions, lacerations, partial-thickness burns, and skin tears) - · Draining wounds

Corplex P/Theracor P/Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Corplex P/Theracor P/Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.

Corplex P/Theracor P/Allacor P is indicated for use in the management of the following wounds: - Partial and full-thickness wounds - Pressure ulcers - Venous ulcers - Diabetic ulcers - Chronic vascular ulcers - Tunneled/undermined wounds - Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) - Trauma wounds (abrasions, lacerations, partial-thickness burns, and skin tears) - Draining wounds

Corplex P/Theracor P/Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Corplex P/Theracor P/Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.